Translational Development...

10.19
0.00 (0.02%)
At close: Mar 25, 2025, 9:34 AM
10.11
-0.77%
Pre-market: Mar 28, 2025, 07:00 AM EDT

Translational Development Acquisition Income Statement

Year FY23 FY22
Revenue n/a n/a
Cost of Revenue n/a n/a
Gross Profit n/a n/a
Operating Income n/a -70.66K
Interest Income n/a n/a
Pretax Income -485.55K -70.66K
Net Income -485.55K -70.66K
Selling & General & Admin 485.55K 70.66K
Research & Development n/a n/a
Other Expenses n/a n/a
Operating Expenses 485.55K 70.66K
Interest Expense n/a n/a
Selling & Marketing Expenses n/a n/a
Cost & Expenses 485.55K 70.66K
Income Tax n/a n/a
Shares Outstanding (Basic) 4.05M 4.05M
Shares Outstanding (Diluted) 4.05M 4.05M
EPS (Basic) -0.12 -0.02
EPS (Diluted) -0.12 -0.02
EBITDA -485.55K n/a
Depreciation & Amortization n/a 70.66K